The Xoft System is FDA cleared and CE marked for use anywhere in the body, including the treatment of early-stage breast cancer, gynecological cancers and non-melanoma skin cancer. Utilizing its proprietary miniaturized x-ray source, the Xoft System delivers treatment directly to cancerous areas while sparing healthy tissue. It is
isotope-free, requires minimal shielding and offers significant treatment time,
mobility and cost advantages. For more information visit www.xoftinc.com.